Taking oral semaglutide for 6 months helped lower blood sugar levels in 32 people with type 2 diabetes, reducing their HbA1c by about 9% on average.

After 6 months of oral semaglutide treatment, 32 people with type 2 diabetes had lower liver enzyme levels, indicating improved liver health.

After 6 months of oral semaglutide treatment, 32 people with type 2 diabetes had lower blood pressure, with an average drop of about 5%.

In a group of 32 people with type 2 diabetes, taking oral semaglutide for 6 months led to a noticeable drop in body fat, with an average loss of about 17.6% of their initial fat mass.

After 3 months of oral semaglutide treatment, 32 people with type 2 diabetes had a 16% lower score on a test for fatty liver disease.

Half of the 32 people with type 2 diabetes who took oral semaglutide for 6 months lost at least 5% of their body weight.